Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry

Katsuhiro Arai1, Reiko Kunisaki2, Fumihiko Kakuta3

  • 1Division of Gastroenterology, National Center for Child Health and Development, Setagaya, Japan.

Intestinal Research
|August 19, 2020
PubMed

Insights

Japanese children with inflammatory bowel disease (IBD) show distinct characteristics compared to European counterparts. Upper gastrointestinal and perianal Crohn's disease (CD) are more prevalent in Japanese pediatric IBD patients.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Comparative Clinical Studies

Background:

  • Limited registry data exists for pediatric inflammatory bowel disease (IBD) in Asia.
  • Registry networks are crucial for inter-ethnic comparisons of IBD characteristics.
  • Understanding ethnic variations in pediatric IBD is essential for tailored management.

Purpose of the Study:

  • To investigate the epidemiological and clinical features of IBD in Japanese children.
  • To compare the characteristics of pediatric IBD in Japan with those reported in European populations.
  • To identify potential ethnic-specific patterns in pediatric IBD presentation.

Main Methods:

  • A cross-sectional, multicenter registry study involving newly diagnosed Japanese pediatric IBD patients.
  • Utilized the Paris classification system for categorizing IBD features.
  • Compared findings with published data from the EUROKIDS registry.

Main Results:

  • Analysis included 91 Crohn's disease (CD), 146 ulcerative colitis (UC), and 6 IBD-unclassified cases.
  • Japanese pediatric CD patients exhibited significantly more upper gastrointestinal involvement (L4a) and ileocolonic disease (L3).
  • Perianal CD was notably more prevalent in Japanese children (34.1%) compared to European children (9.7%).

Conclusions:

  • Upper gastrointestinal and perianal lesions are more frequent in Japanese pediatric CD patients.
  • Significant differences in disease location and behavior exist between Japanese and European pediatric IBD populations.
  • Highlights the need for culturally sensitive approaches in pediatric IBD care.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
770
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
537
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
715
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
616
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
336
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
673